Clinical Trial Update: Long-term Clinical Study of CN128 in Thalassemia Patients [Phase 2]

View source ↗

Summary

Phase 2 long-term clinical study update for CN128 in thalassemia and iron overload conditions has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Overload
• Thalassemia

Drugs mentioned

• CN128

Snippet

Sponsor: Hangzhou Zede Pharma-Tech Co., Ltd. | Conditions: Thalassemia, Iron Overload | Phase 2 | Status: COMPLETED